Degrees of Health

← Degrees of Health18. Okt. · 22 Min.

A Deep Dive On Fisetin | Dr Juliette Tavenier

A Deep Dive On Fisetin | Dr Juliette Tavenier18. Okt.22 Min.

Could removing damaged cells help us age better and reduce the risk of age-related diseases? In this episode, Ben Hopkins sits down with researcher **Juliette Taverner** to explore the science of cellular senescence, senolytics, and the potential of compounds like fisetin in the field of longevity research.

As we age, some damaged cells stop dividing but remain active, releasing inflammatory signals that can affect surrounding tissues. These are known as *senescent cells*, sometimes nicknamed “zombie cells”. Scientists are investigating whether senolytics, compounds designed to selectively eliminate these cells, could help reduce their harmful effects and improve health as we age.

🧬 What You'll Learn

**Cellular senescence:** What happens when damaged cells stop dividing but continue to release inflammatory signals.

**Senolytics vs. senomorphics:** How these two approaches differ in targeting senescent cells and their effects.

**Fisetin and longevity:** Why this plant-derived compound has attracted interest in ageing research, and what we still don't know about its effects in humans.

**Clinical trials:** How researchers are investigating fisetin in older adults and exploring different treatment approaches.

**Measuring biological ageing:** Why identifying and quantifying senescent cells in living humans remains a major scientific challenge.

**SUPAR as a biomarker:** How this blood-based marker may help researchers investigate chronic inflammation and biological ageing.

**Immune system decline:** How immunosenescence may contribute to the accumulation of senescent cells as we age.

**Safety and supplementation:** Potential risks, drug interactions, bioavailability challenges and why high-dose fisetin should not be assumed to be safe or effective.

⏱️ Chapters